Study of DF6215 in Patients With Advanced Solid Tumors
Dragonfly Therapeutics
Dragonfly Therapeutics
University of California, San Diego
Adaptimmune
University Health Network, Toronto
University Hospital, Lille
Bayer
UNC Lineberger Comprehensive Cancer Center
BioAtla, Inc.
AbbVie
Washington University School of Medicine
Palleon Pharmaceuticals, Inc.
University of California, San Diego
Medical College of Wisconsin
Mayo Clinic
Hoffmann-La Roche
Thomas Jefferson University
Scholar Rock, Inc.
Revolution Medicines, Inc.
Tvardi Therapeutics, Incorporated
Intensity Therapeutics, Inc.
Inova Health Care Services
Cedars-Sinai Medical Center
Cedars-Sinai Medical Center
Immatics US, Inc.
University of Michigan Rogel Cancer Center
Cyteir Therapeutics, Inc.
Helsinki University Central Hospital
Mahidol University
Astellas Pharma Inc
GlaxoSmithKline
Queen Mary University of London
University of Nove de Julho
Cedars-Sinai Medical Center
Massachusetts General Hospital
Brooklyn ImmunoTherapeutics, LLC
University of Chicago
CytomX Therapeutics
Apexigen America, Inc.
University of Chicago
Universidad de Granada
University of Kansas Medical Center
Novartis
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
University of Kentucky
AbbVie
Vanderbilt University Medical Center
Quadriga Biosciences, Inc.
Institut de Cancérologie de Lorraine
University Hospital, Ghent
Université de Sherbrooke